Skip to main content
. 2022 Aug 24;12:985089. doi: 10.3389/fonc.2022.985089

Figure 2.

Figure 2

Comparison of patient survival between patients with high and low levels of serum exosomal miR-200c-3p. (A) Tumor-free survival curves; (B) The overall survival curves.